Pediatrix Medical Group (NYSE:MD) Issues Earnings Results

Pediatrix Medical Group (NYSE:MD) posted its earnings results on Thursday. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12, Zacks reports. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%.

Pediatrix Medical Group Stock Up 23.8 %

NYSE:MD traded up $3.36 during trading hours on Thursday, reaching $17.47. 532,883 shares of the stock were exchanged, compared to its average volume of 485,719. The stock has a market cap of $1.50 billion, a PE ratio of -5.70, a PEG ratio of 1.44 and a beta of 1.57. Pediatrix Medical Group has a twelve month low of $6.62 and a twelve month high of $17.49. The firm has a 50 day moving average of $13.80 and a 200 day moving average of $12.88. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on MD shares. Jefferies Financial Group upped their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Truist Financial dropped their price objective on Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Monday, January 6th. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Deutsche Bank Aktiengesellschaft increased their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $16.25.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.